Literature DB >> 33498197

The Brain-Gut Axis: Psychological Functioning and Inflammatory Bowel Diseases.

Spyros Peppas1, Claudia Pansieri2,3, Daniele Piovani2,3, Silvio Danese2,3, Laurent Peyrin-Biroulet4, Andreas G Tsantes5, Enrico Brunetta2,3, Argirios E Tsantes5, Stefanos Bonovas2,3.   

Abstract

The brain-gut axis represents a complex bi-directional system comprising multiple interconnections between the neuroendocrine pathways, the autonomous nervous system and the gastrointestinal tract. Inflammatory bowel disease (IBD), comprising Crohn's disease and ulcerative colitis, is a chronic, relapsing-remitting inflammatory disorder of the gastrointestinal tract with a multifactorial etiology. Depression and anxiety are prevalent among patients with chronic disorders characterized by a strong immune component, such as diabetes mellitus, cancer, multiple sclerosis, rheumatoid arthritis and IBD. Although psychological problems are an important aspect of morbidity and of impaired quality of life in patients with IBD, depression and anxiety continue to be under-diagnosed. There is lack of evidence regarding the exact mechanisms by which depression, anxiety and cognitive dysfunction may occur in these patients, and whether psychological disorders are the result of disease activity or determinants of the IBD occurrence. In this comprehensive review, we summarize the role of the brain-gut axis in the psychological functioning of patients with IBD, and discuss current preclinical and clinical data on the topic and therapeutic strategies potentially useful for the clinical management of these patients. Personalized pathways of psychological supports are needed to improve the quality of life in patients with IBD.

Entities:  

Keywords:  anti-depressive agents; gastroenterology; inflammatory bowel diseases; mental disorders; neuropsychology

Year:  2021        PMID: 33498197      PMCID: PMC7863941          DOI: 10.3390/jcm10030377

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  207 in total

Review 1.  Etiology and Treatment of Pain and Psychosocial Issues in Patients With Inflammatory Bowel Diseases.

Authors:  Miguel Regueiro; Julia B Greer; Eva Szigethy
Journal:  Gastroenterology       Date:  2016-11-02       Impact factor: 22.682

2.  Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys.

Authors:  Esme Fuller-Thomson; Joanne Sulman
Journal:  Inflamm Bowel Dis       Date:  2006-08       Impact factor: 5.325

Review 3.  Depression and anxiety in patients with Inflammatory Bowel Disease: A systematic review.

Authors:  Rachel Neuendorf; Aubrey Harding; Noelle Stello; Douglas Hanes; Helané Wahbeh
Journal:  J Psychosom Res       Date:  2016-06-06       Impact factor: 3.006

4.  Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part II.

Authors:  Simon R Knowles; Laurie Keefer; Helen Wilding; Catherine Hewitt; Lesley A Graff; Antonina Mikocka-Walus
Journal:  Inflamm Bowel Dis       Date:  2018-04-23       Impact factor: 5.325

5.  Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study.

Authors:  Richard B Gearry; Peter M Irving; Jacqueline S Barrett; Debbie M Nathan; Sue J Shepherd; Peter R Gibson
Journal:  J Crohns Colitis       Date:  2008-12-06       Impact factor: 9.071

6.  Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines.

Authors:  J D Johnson; J Campisi; C M Sharkey; S L Kennedy; M Nickerson; B N Greenwood; M Fleshner
Journal:  Neuroscience       Date:  2005-09-13       Impact factor: 3.590

7.  Evidence of Bidirectional Associations Between Perceived Stress and Symptom Activity: A Prospective Longitudinal Investigation in Inflammatory Bowel Disease.

Authors:  Kathryn A Sexton; John R Walker; Lesley A Graff; Matthew T Bernstein; Brooke Beatie; Norine Miller; Michael Sargent; Laura E Targownik
Journal:  Inflamm Bowel Dis       Date:  2017-03       Impact factor: 5.325

8.  Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis.

Authors:  Ashwin N Ananthakrishnan; Millie D Long; Christopher F Martin; Robert S Sandler; Michael D Kappelman
Journal:  Clin Gastroenterol Hepatol       Date:  2013-02-01       Impact factor: 11.382

9.  A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.

Authors:  Charles L Raison; Robin E Rutherford; Bobbi J Woolwine; Chen Shuo; Pamela Schettler; Daniel F Drake; Ebrahim Haroon; Andrew H Miller
Journal:  JAMA Psychiatry       Date:  2013-01       Impact factor: 21.596

Review 10.  Adherence to anti-TNF therapy in inflammatory bowel diseases: a systematic review.

Authors:  Anthony Lopez; Vincent Billioud; Carina Peyrin-Biroulet; Laurent Peyrin-Biroulet
Journal:  Inflamm Bowel Dis       Date:  2013-06       Impact factor: 5.325

View more
  6 in total

1.  Implementing Collaborative Care Management of Behavioral Health for Patients with Inflammatory Bowel Disease.

Authors:  Christine B Flicek; Nathaniel A Sowa; Millie D Long; Hans H Herfarth; Spencer D Dorn
Journal:  Inflamm Intest Dis       Date:  2021-12-02

Review 2.  Inflammation From Peripheral Organs to the Brain: How Does Systemic Inflammation Cause Neuroinflammation?

Authors:  Yuanjie Sun; Yoshihisa Koyama; Shoichi Shimada
Journal:  Front Aging Neurosci       Date:  2022-06-16       Impact factor: 5.702

3.  Global trends in research on irritable bowel syndrome and the brain-gut axis: Bibliometrics and visualization analysis.

Authors:  Peng-Ning Wu; Shuai Xiong; Peng Zhong; Wan-Qing Yang; Min Chen; Tai-Chun Tang
Journal:  Front Pharmacol       Date:  2022-09-08       Impact factor: 5.988

4.  Acute stress induces an inflammation dominated by innate immunity represented by neutrophils in mice.

Authors:  Lanjing Tang; Nannan Cai; Yao Zhou; Yi Liu; Jingxia Hu; Yalin Li; Shuying Yi; Wengang Song; Li Kang; Hao He
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

5.  Causal relationship between bipolar disorder and inflammatory bowel disease: A bidirectional two-sample mendelian randomization study.

Authors:  Zhe Wang; Xinyu Wang; Xushi Zhao; Zhaoliang Hu; Dongwei Sun; Donglei Wu; Yanan Xing
Journal:  Front Genet       Date:  2022-09-20       Impact factor: 4.772

Review 6.  The effects of different stress on intestinal mucosal barrier and intestinal microecology were discussed based on three typical animal models.

Authors:  Junfeng Guo; Xiaokun Lou; Wenyan Gong; Jing Bian; Yuhan Liao; Qi Wu; Qibin Jiao; Xingwei Zhang
Journal:  Front Cell Infect Microbiol       Date:  2022-09-29       Impact factor: 6.073

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.